--GUIDANCE: (IOVA) Iovance Biotherapeutics Expects 2026 Revenue Range $410M to $420M, vs. FactSet Est of $402.8M

MT newswire2026/09/29 11:10

By:MT newswire

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Trump-Putin Diesel Deal: Will US Crude Oil Fall Below $90?

Coinpedia•2026/10/10 11:30

Terrifying iPhone Exploit Threatens Crypto Holders

UToday•2026/10/10 10:21

Hedera launches tokenized stocks, HBAR eyes stability above $0.0805

Cointurk•2026/10/10 09:27

These Institutions Are Preparing for Something Big Around XRP

TimesTabloid•2026/10/10 08:00